Clinical Trial Update: High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose sequential therapy with autologous stem cell rescue in multiple myeloma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Stanford University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED